Loading…

Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation

B cell differentiation into Ab-secreting plasma cells requires transcriptional, metabolic, and epigenetic remodeling. Histone H3 lysine 27 trimethylation (H3K27me3), a histone modification associated with gene silencing, is dynamically regulated during B cell differentiation. Although several studie...

Full description

Saved in:
Bibliographic Details
Published in:ImmunoHorizons 2021-12, Vol.5 (12), p.918-930
Main Authors: Kania, Anna K, Guo, Muyao, Scharer, Christopher D, Boss, Jeremy M
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c2747-dd07ba0f6ee4c28e742329dec043691412cd7e3ab4850ad7f12ccc252225bc613
cites cdi_FETCH-LOGICAL-c2747-dd07ba0f6ee4c28e742329dec043691412cd7e3ab4850ad7f12ccc252225bc613
container_end_page 930
container_issue 12
container_start_page 918
container_title ImmunoHorizons
container_volume 5
creator Kania, Anna K
Guo, Muyao
Scharer, Christopher D
Boss, Jeremy M
description B cell differentiation into Ab-secreting plasma cells requires transcriptional, metabolic, and epigenetic remodeling. Histone H3 lysine 27 trimethylation (H3K27me3), a histone modification associated with gene silencing, is dynamically regulated during B cell differentiation. Although several studies have focused on mechanisms involving the gain of this modification in plasmablasts (PB), the role of active demethylation of H3K27me3 by ubiquitously transcribed tetratricopeptide repeat, X chromosome (UTX) and Jumonji domain-containing protein 3 (JMDJ3) during B cell differentiation has not been examined. In this study, this process was assessed using a pharmacological inhibitor of UTX and JMJD3, GSK-J4. Treatment of ex vivo stimulated mouse B cells with GSK-J4 led to an increase in PB frequency without affecting the ability of the newly formed PB to secrete Abs. Consistent with the role of UTX and JMJD3 in promoting gene expression, the majority of differentially expressed were downregulated upon GSK-J4 treatment. GSK-J4-treated cells downregulated genes associated with signaling and P53 pathways. Inhibitor treated cells upregulated genes associated with cell cycle and proliferation, which correlated with an increase in actively proliferating cells. Unexpectedly, a majority of the downregulated transcripts corresponded to genes that in the wild-type setting were genes that gain H3K27me3 and downregulated in PB. Together, our results show that UTX and JMDJ3 are required to restrain B cell differentiation and suggest that they function as a rheostat for H3K27me3 to control this process.
doi_str_mv 10.4049/immunohorizons.2000087
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2615917868</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2615917868</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2747-dd07ba0f6ee4c28e742329dec043691412cd7e3ab4850ad7f12ccc252225bc613</originalsourceid><addsrcrecordid>eNpVkD1PwzAQhi0EolXpX6gysqTYZydORiiUVlSCAebIcS6qURwXOxnKr2-qFgQ33Jfe9056CJkxOhdU5HfG2r51W-fNt2vDHOgQmbwgY0gkj6XkcPmnH5FpCJ-DBJigkotrMuIiyyijyZg8rNutKU1nXBu5OlrxF5AWefSIFrvtvlEBQ_TmnXXdsRlmq8ohd9HSeauOvhtyVasm4PRcJ-Rj-fS-WMWb1-f14n4Ta5BCxlVFZalonSIKDRlKARzyCjUVPM2ZYKAriVyVIkuoqmQ9LLSGBACSUqeMT8jt6e7Ou68eQ1dYEzQ2jWrR9aGAlCU5k1maDdL0JNXeheCxLnbeWOX3BaPFEWHxH2FxRjgYZ-cffWmx-rX9AOMH1r5wpg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2615917868</pqid></control><display><type>article</type><title>Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation</title><source>Oxford Open</source><creator>Kania, Anna K ; Guo, Muyao ; Scharer, Christopher D ; Boss, Jeremy M</creator><creatorcontrib>Kania, Anna K ; Guo, Muyao ; Scharer, Christopher D ; Boss, Jeremy M</creatorcontrib><description>B cell differentiation into Ab-secreting plasma cells requires transcriptional, metabolic, and epigenetic remodeling. Histone H3 lysine 27 trimethylation (H3K27me3), a histone modification associated with gene silencing, is dynamically regulated during B cell differentiation. Although several studies have focused on mechanisms involving the gain of this modification in plasmablasts (PB), the role of active demethylation of H3K27me3 by ubiquitously transcribed tetratricopeptide repeat, X chromosome (UTX) and Jumonji domain-containing protein 3 (JMDJ3) during B cell differentiation has not been examined. In this study, this process was assessed using a pharmacological inhibitor of UTX and JMJD3, GSK-J4. Treatment of ex vivo stimulated mouse B cells with GSK-J4 led to an increase in PB frequency without affecting the ability of the newly formed PB to secrete Abs. Consistent with the role of UTX and JMJD3 in promoting gene expression, the majority of differentially expressed were downregulated upon GSK-J4 treatment. GSK-J4-treated cells downregulated genes associated with signaling and P53 pathways. Inhibitor treated cells upregulated genes associated with cell cycle and proliferation, which correlated with an increase in actively proliferating cells. Unexpectedly, a majority of the downregulated transcripts corresponded to genes that in the wild-type setting were genes that gain H3K27me3 and downregulated in PB. Together, our results show that UTX and JMDJ3 are required to restrain B cell differentiation and suggest that they function as a rheostat for H3K27me3 to control this process.</description><identifier>ISSN: 2573-7732</identifier><identifier>EISSN: 2573-7732</identifier><identifier>DOI: 10.4049/immunohorizons.2000087</identifier><identifier>PMID: 34880105</identifier><language>eng</language><publisher>United States</publisher><subject>Animals ; Benzazepines - pharmacology ; Cell Differentiation - drug effects ; Histone Demethylases - metabolism ; Jumonji Domain-Containing Histone Demethylases - metabolism ; Mice ; Mice, Inbred C57BL ; Plasma Cells - drug effects ; Plasma Cells - metabolism ; Pyrimidines - pharmacology ; Signal Transduction - drug effects</subject><ispartof>ImmunoHorizons, 2021-12, Vol.5 (12), p.918-930</ispartof><rights>Copyright © 2021 The Authors.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c2747-dd07ba0f6ee4c28e742329dec043691412cd7e3ab4850ad7f12ccc252225bc613</citedby><cites>FETCH-LOGICAL-c2747-dd07ba0f6ee4c28e742329dec043691412cd7e3ab4850ad7f12ccc252225bc613</cites><orcidid>0000-0002-5819-5694 ; 0000-0003-1347-0848 ; 0000-0002-2432-1840 ; 0000-0001-7716-8504</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34880105$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kania, Anna K</creatorcontrib><creatorcontrib>Guo, Muyao</creatorcontrib><creatorcontrib>Scharer, Christopher D</creatorcontrib><creatorcontrib>Boss, Jeremy M</creatorcontrib><title>Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation</title><title>ImmunoHorizons</title><addtitle>Immunohorizons</addtitle><description>B cell differentiation into Ab-secreting plasma cells requires transcriptional, metabolic, and epigenetic remodeling. Histone H3 lysine 27 trimethylation (H3K27me3), a histone modification associated with gene silencing, is dynamically regulated during B cell differentiation. Although several studies have focused on mechanisms involving the gain of this modification in plasmablasts (PB), the role of active demethylation of H3K27me3 by ubiquitously transcribed tetratricopeptide repeat, X chromosome (UTX) and Jumonji domain-containing protein 3 (JMDJ3) during B cell differentiation has not been examined. In this study, this process was assessed using a pharmacological inhibitor of UTX and JMJD3, GSK-J4. Treatment of ex vivo stimulated mouse B cells with GSK-J4 led to an increase in PB frequency without affecting the ability of the newly formed PB to secrete Abs. Consistent with the role of UTX and JMJD3 in promoting gene expression, the majority of differentially expressed were downregulated upon GSK-J4 treatment. GSK-J4-treated cells downregulated genes associated with signaling and P53 pathways. Inhibitor treated cells upregulated genes associated with cell cycle and proliferation, which correlated with an increase in actively proliferating cells. Unexpectedly, a majority of the downregulated transcripts corresponded to genes that in the wild-type setting were genes that gain H3K27me3 and downregulated in PB. Together, our results show that UTX and JMDJ3 are required to restrain B cell differentiation and suggest that they function as a rheostat for H3K27me3 to control this process.</description><subject>Animals</subject><subject>Benzazepines - pharmacology</subject><subject>Cell Differentiation - drug effects</subject><subject>Histone Demethylases - metabolism</subject><subject>Jumonji Domain-Containing Histone Demethylases - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Plasma Cells - drug effects</subject><subject>Plasma Cells - metabolism</subject><subject>Pyrimidines - pharmacology</subject><subject>Signal Transduction - drug effects</subject><issn>2573-7732</issn><issn>2573-7732</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNpVkD1PwzAQhi0EolXpX6gysqTYZydORiiUVlSCAebIcS6qURwXOxnKr2-qFgQ33Jfe9056CJkxOhdU5HfG2r51W-fNt2vDHOgQmbwgY0gkj6XkcPmnH5FpCJ-DBJigkotrMuIiyyijyZg8rNutKU1nXBu5OlrxF5AWefSIFrvtvlEBQ_TmnXXdsRlmq8ohd9HSeauOvhtyVasm4PRcJ-Rj-fS-WMWb1-f14n4Ta5BCxlVFZalonSIKDRlKARzyCjUVPM2ZYKAriVyVIkuoqmQ9LLSGBACSUqeMT8jt6e7Ou68eQ1dYEzQ2jWrR9aGAlCU5k1maDdL0JNXeheCxLnbeWOX3BaPFEWHxH2FxRjgYZ-cffWmx-rX9AOMH1r5wpg</recordid><startdate>20211208</startdate><enddate>20211208</enddate><creator>Kania, Anna K</creator><creator>Guo, Muyao</creator><creator>Scharer, Christopher D</creator><creator>Boss, Jeremy M</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-5819-5694</orcidid><orcidid>https://orcid.org/0000-0003-1347-0848</orcidid><orcidid>https://orcid.org/0000-0002-2432-1840</orcidid><orcidid>https://orcid.org/0000-0001-7716-8504</orcidid></search><sort><creationdate>20211208</creationdate><title>Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation</title><author>Kania, Anna K ; Guo, Muyao ; Scharer, Christopher D ; Boss, Jeremy M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2747-dd07ba0f6ee4c28e742329dec043691412cd7e3ab4850ad7f12ccc252225bc613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animals</topic><topic>Benzazepines - pharmacology</topic><topic>Cell Differentiation - drug effects</topic><topic>Histone Demethylases - metabolism</topic><topic>Jumonji Domain-Containing Histone Demethylases - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Plasma Cells - drug effects</topic><topic>Plasma Cells - metabolism</topic><topic>Pyrimidines - pharmacology</topic><topic>Signal Transduction - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kania, Anna K</creatorcontrib><creatorcontrib>Guo, Muyao</creatorcontrib><creatorcontrib>Scharer, Christopher D</creatorcontrib><creatorcontrib>Boss, Jeremy M</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>ImmunoHorizons</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kania, Anna K</au><au>Guo, Muyao</au><au>Scharer, Christopher D</au><au>Boss, Jeremy M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation</atitle><jtitle>ImmunoHorizons</jtitle><addtitle>Immunohorizons</addtitle><date>2021-12-08</date><risdate>2021</risdate><volume>5</volume><issue>12</issue><spage>918</spage><epage>930</epage><pages>918-930</pages><issn>2573-7732</issn><eissn>2573-7732</eissn><abstract>B cell differentiation into Ab-secreting plasma cells requires transcriptional, metabolic, and epigenetic remodeling. Histone H3 lysine 27 trimethylation (H3K27me3), a histone modification associated with gene silencing, is dynamically regulated during B cell differentiation. Although several studies have focused on mechanisms involving the gain of this modification in plasmablasts (PB), the role of active demethylation of H3K27me3 by ubiquitously transcribed tetratricopeptide repeat, X chromosome (UTX) and Jumonji domain-containing protein 3 (JMDJ3) during B cell differentiation has not been examined. In this study, this process was assessed using a pharmacological inhibitor of UTX and JMJD3, GSK-J4. Treatment of ex vivo stimulated mouse B cells with GSK-J4 led to an increase in PB frequency without affecting the ability of the newly formed PB to secrete Abs. Consistent with the role of UTX and JMJD3 in promoting gene expression, the majority of differentially expressed were downregulated upon GSK-J4 treatment. GSK-J4-treated cells downregulated genes associated with signaling and P53 pathways. Inhibitor treated cells upregulated genes associated with cell cycle and proliferation, which correlated with an increase in actively proliferating cells. Unexpectedly, a majority of the downregulated transcripts corresponded to genes that in the wild-type setting were genes that gain H3K27me3 and downregulated in PB. Together, our results show that UTX and JMDJ3 are required to restrain B cell differentiation and suggest that they function as a rheostat for H3K27me3 to control this process.</abstract><cop>United States</cop><pmid>34880105</pmid><doi>10.4049/immunohorizons.2000087</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-5819-5694</orcidid><orcidid>https://orcid.org/0000-0003-1347-0848</orcidid><orcidid>https://orcid.org/0000-0002-2432-1840</orcidid><orcidid>https://orcid.org/0000-0001-7716-8504</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2573-7732
ispartof ImmunoHorizons, 2021-12, Vol.5 (12), p.918-930
issn 2573-7732
2573-7732
language eng
recordid cdi_proquest_miscellaneous_2615917868
source Oxford Open
subjects Animals
Benzazepines - pharmacology
Cell Differentiation - drug effects
Histone Demethylases - metabolism
Jumonji Domain-Containing Histone Demethylases - metabolism
Mice
Mice, Inbred C57BL
Plasma Cells - drug effects
Plasma Cells - metabolism
Pyrimidines - pharmacology
Signal Transduction - drug effects
title Inhibition of H3K27me3 Demethylases Promotes Plasmablast Formation
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-12T01%3A18%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Inhibition%20of%20H3K27me3%20Demethylases%20Promotes%20Plasmablast%20Formation&rft.jtitle=ImmunoHorizons&rft.au=Kania,%20Anna%20K&rft.date=2021-12-08&rft.volume=5&rft.issue=12&rft.spage=918&rft.epage=930&rft.pages=918-930&rft.issn=2573-7732&rft.eissn=2573-7732&rft_id=info:doi/10.4049/immunohorizons.2000087&rft_dat=%3Cproquest_cross%3E2615917868%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c2747-dd07ba0f6ee4c28e742329dec043691412cd7e3ab4850ad7f12ccc252225bc613%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2615917868&rft_id=info:pmid/34880105&rfr_iscdi=true